These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead. Giannini EG; Farinati F; Trevisani F Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475 [No Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma tumour markers: current role and expectations. Rich N; Singal AG Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312 [TBL] [Abstract][Full Text] [Related]
7. Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma. He J; Liu Y EBioMedicine; 2016 Oct; 12():4-5. PubMed ID: 27665049 [No Abstract] [Full Text] [Related]
8. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma. Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109 [TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma. Yang XR; Guo W Ann Surg Oncol; 2019 Dec; 26(Suppl 3):529-530. PubMed ID: 30519762 [No Abstract] [Full Text] [Related]
11. Serum tumor markers for detection of hepatocellular carcinoma. Zhou L; Liu J; Luo F World J Gastroenterol; 2006 Feb; 12(8):1175-81. PubMed ID: 16534867 [TBL] [Abstract][Full Text] [Related]
12. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma. Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095 [No Abstract] [Full Text] [Related]
14. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580 [No Abstract] [Full Text] [Related]
15. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction. Aoyagi Y; Tamura Y; Suda T J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297 [No Abstract] [Full Text] [Related]
16. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Fartoux L; Decaens T Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297 [TBL] [Abstract][Full Text] [Related]
18. Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients. Zhang Y; Huang P; Zheng Y; Wang Y; Yuan Y; He W; Liu W; Yang Z; Wang C; Yuan Y; Li B Am Surg; 2019 Jun; 85(6):e309-e312. PubMed ID: 31267923 [No Abstract] [Full Text] [Related]